BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30765611)

  • 1. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.
    Dong S; Huang F; Zhang H; Chen Q
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30765611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
    Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
    Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
    Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
    Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
    Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic value of
    Xing Z; Wang X; Liu J; Zhang M; Feng K; Wang X
    J Int Med Res; 2021 Apr; 49(4):300060520980647. PubMed ID: 33896262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma.
    Hao Q; Wu H; Liu E; Wang L
    BMC Cancer; 2023 Oct; 23(1):995. PubMed ID: 37853361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A
    J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
    Zhang Q; Wang Y; Xue F
    Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation.
    Xu Y; Wang Y; Chen Q; Yao T; Qiu J; Ni L; Chen H; Liang T
    Pancreatology; 2023 Dec; 23(8):1003-1013. PubMed ID: 37923686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic values of spindle checkpoint protein BUB1B in triple negative breast cancer].
    Zhang PC; Zhong XR; Zheng H; Li L; Chen F; Shen MJ; Li YJ; Chen H; Cao SY; Bu H; Ye F
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):645-649. PubMed ID: 34078054
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-malarial drug dihydroartemisinin downregulates the expression levels of
    Hao L; Li S; Peng Q; Guo Y; Ji J; Zhang Z; Xue Y; Liu Y; Shi X
    Oncol Lett; 2021 Sep; 22(3):653. PubMed ID: 34386075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and survival significance of sodium glucose transporters in pancreatic cancer.
    Du J; Gu J; Deng J; Kong L; Guo Y; Jin C; Bao Y; Fu D; Li J
    BMC Cancer; 2022 Jan; 22(1):116. PubMed ID: 35090421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma.
    Qin LT; Huang SW; Huang ZG; Dang YW; Fang YY; He J; Niu YT; Lin CX; Wu JY; Wei ZX
    BMC Med Genomics; 2022 Dec; 15(1):272. PubMed ID: 36577966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells.
    Pecoraro C; Parrino B; Cascioferro S; Puerta A; Avan A; Peters GJ; Diana P; Giovannetti E; Carbone D
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
    Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
    Front Oncol; 2022; 12():827051. PubMed ID: 35433491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
    Peng W; Li W; Zhang X; Cen W; Liu Y
    J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
    Deng H; Hang Q; Shen D; Ying H; Zhang Y; Qian X; Chen M
    Front Mol Biosci; 2021; 8():653805. PubMed ID: 34307447
    [No Abstract]   [Full Text] [Related]  

  • 19. BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability.
    Tang X; Guo M; Ding P; Deng Z; Ke M; Yuan Y; Zhou Y; Lin Z; Li M; Gu C; Gu X; Yang Y
    Signal Transduct Target Ther; 2021 Oct; 6(1):361. PubMed ID: 34620840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
    Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
    Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.